AlphaLens
Research
财报OverweightTP $68.00005月10日 · Morgan Stanley

ACM Research EPS Estimates Trimmed Slightly, PT Maintained at $68; Positive on China WFE Demand

ACMR
中文EN⚠ quality lint: see notes

ACM Research: Risk/Reward Asymmetric to the Upside on China WFE Demand and Margin Expansion

Core Conclusion

ACM Research (ACMR) offers a favorable risk/reward profile driven by structural China WFE demand and accelerating market share gains. We maintain Overweight with a $68 price target (25x 2026e EPS), implying ~13% upside from $59.85. The base case embeds a 19% revenue CAGR (2025-28e) and gradual gross margin expansion, but the bull case of $107 (39x) reflects plausible upside from faster-than-expected China spending and product cycle penetration at YMTC and CXMT. The asymmetric skew is positive, with bear case at $24 (8x) requiring a catastrophic order collapse or severe export restriction.

What the Market May Be Underestimating

  • Pace of market share gains in China: ACM’s revenue to memory customers is expected to grow from $341mn (2025) to $553mn (2028e, CAGR ~17%), while front-end logic sales expand from $265mn to $417mn. New product cycles at key domestic fabs (YMTC, CXMT) are not fully priced into consensus revenue trajectory. The long-term $4bn revenue target reflects management’s increased confidence, underpinning a >25% CAGR in the bull case.
  • 2027-28 EPS upside: Consensus estimates for 2027-28 may be too low because margin expansion from better product mix is not fully captured. Our 2027e EPS of $3.73 and 2028e EPS of $4.25 are 2% and 1% above prior, driven by higher gross margin assumptions. If ACM sustains a 45%+ gross margin by 2027 (vs. 44.4% in 2025), EPS could exceed current forecasts.

Evidence Chain

1. China WFE Demand Remains Strong

  • Rising capex investments by Chinese logic and memory fabs underpin a robust 2026 WFE outlook. Sales to memory customers alone grow at a 17% CAGR through 2028e. Total revenue is projected to reach $1.1bn in 2026e, $1.24bn in 2027e, and $1.50bn in 2028e.
  • Investment implication: ACM’s China-centric revenue base (~60-70% of total) is a structural tailwind that insulates it from global semi cyclicality, provided no new severe export controls.

2. Market Share Gains Accelerate

  • ACM’s penetration in China has been stronger than expected, driven by new product launches and successful qualification at key customers. The long-term revenue target of $4bn implies a ~25% CAGR if achieved, well above the base case 19% CAGR.
  • Investment implication: The bull case ($107) assumes >25% CAGR to 2028e, which would be a natural outcome if ACM captures share in wet cleaning and other advanced processes at multiple domestic fabs simultaneously.

3. Gross Margin Expansion Expected Despite Near-Term Pressure

  • Long-term gross margin target of 42-48% is achievable as product mix improves. While 1H26 may see margin compression due to competition and inventory provisions, the trajectory improves in 2H26 and beyond. 2026e gross margin is assumed at ~45%, flat from 44.4% in 2025, then rising.
  • Investment implication: If ACM sustains 45%+ gross margins by 2027, the residual income model valuation ($68) is well-supported. Even a 200bps miss would still yield a PT near $60.

4. Valuation Supportive Across Scenarios

  • Base case PT of $68 uses residual income model (WACC 10.1%, medium-term growth 11%, terminal growth 4%). The implied 25x 2026e P/E is reasonable for a company with 19% revenue CAGR and expanding margins. Consensus rating is 88% Overweight, reflecting broad institutional conviction.
  • Investment implication: At current $59.85, the stock trades at 21.7x 2026e EPS — a discount to historical average and to peers. The bear case ($24, 8x) seems remote absent a total order freeze.

Key Divergences & Risks

  • Downside risk 1: Weaker-than-expected equipment demand from China if fab capacity ramp-ups slow or customer orders are delayed. ACM’s revenue concentration (60-70% China) makes it vulnerable to a pullback in domestic semi spending.
  • Downside risk 2: Tighter US export controls on Chinese semiconductor equipment could disrupt ACM’s operations or supply chain. While ACM is China-headquartered, its reliance on US components or IP could be impacted.
  • Downside risk 3: Intense competition and inventory provisions may pressure gross margins below the 42-48% target range. 1H26 margin softness is already flagged, but if it persists into 2027, the bull case becomes less plausible.

Valuation & Trade Implication

Maintain Overweight rating with a $68 price target (25x 2026e EPS). The base case offers ~13% upside. The bull case ($107) assumes >25% revenue CAGR and 50%+ gross margin in 2026, driving 39x implied P/E — achievable if China WFE spending accelerates and ACM’s share gains run above base. The bear case ($24) assumes <5% revenue growth, gross margin below 40%, and 8x P/E, which would require severe adverse developments. The asymmetric risk/reward skews positive. Investors should use any pullback from current levels to build positions, given the structural growth trajectory and limited downside catalysts in the near term.

(No appendix tables included; revenue and valuation details are embedded in evidence chain.)

Related (同 ticker)